Delanzomib T6027
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
CEP-18770 is an orally active inhibitor of the chymotrypsin-like activity of proteasome (IC50: 3.8 nM). It only marginally inhibits the tryptic and peptidylglutamyl activities of the proteosome.
CAS nr:
847499-27-8
Purity:
98%
Molecular Weight:
413,28
SMILES:
B([C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)c1cccc(n1)c1ccccc1)(O)O
Formula:
C21H28BN3O5
Pathway:
Proteases/Proteasome,Ubiquitination,NF-_b,Apoptosis
Target:
Proteasome,Proteasome,NF-_B,Apoptosis
